MarketPeel
Insider Trading Intelligence
Pricing
…
JL

Joy Liu

VRTX
SVP, GENERAL COUNSEL · VERTEX PHARMACEUTICALS INC / MA · CIK 0001847529
FILING MIX · LIFETIME8%/92%
BUYS
3
SELLS
33
TOTAL VALUE
$4.95M
COMPANIES
1
ACTIVE SINCE
Mar 2021
HOLDINGS NOW
19,959
AVG SELL PX
$295.03
TRADE KIND
SHOWING 36 / 36
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
29 backtested trades · 8 horizons · 10 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Joy Liu, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d29+51.72%-1.05%+0.07%-1.12%-1.61%—
14d29+58.62%-2.27%-0.48%-1.79%-1.72%—
30d29+58.62%-2.42%-1.06%-1.65%-0.60%—
60d29+37.93%+1.86%-3.83%+5.76%+9.26%—
90d29(1 pending)+32.14%+3.47%+2.16%+1.73%+3.79%—
180d29(3 pending)+53.85%+3.32%+3.16%+0.16%+1.36%—
1y29(3 pending)+0.00%+20.77%+6.41%+14.36%+9.53%—
2y29(3 pending)+0.00%+52.56%+24.11%+28.45%+28.30%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
VRTX · 19,959 shares · as of Jun 1, 2026
05,70311,40617,10822,81120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 3 buys / 33 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
828$439.91$364.2K19,959Jun 1, 2026Jun 3, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
1,104$425.02$469.2K20,729May 1, 2026May 5, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
978$449.17$439.3K21,833Apr 1, 2026Apr 3, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
892$495.96$442.4K22,811Mar 2, 2026Mar 4, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
1,743$305.01$531.6K9,905Aug 15, 2022Aug 17, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
300$305.57$91.7K9,605Aug 15, 2022Aug 17, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
698$301.63$210.5K12,448Aug 15, 2022Aug 17, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
206$300.26$61.9K13,146Aug 15, 2022Aug 17, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
700$303.99$212.8K11,648Aug 15, 2022Aug 17, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
100$302.35$30.2K12,348Aug 15, 2022Aug 17, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
36$300.32$10.8K13,352Aug 10, 2022Aug 12, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
946$300.00$283.8K13,388Aug 9, 2022Aug 10, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
25$250.77$6.3K14,442May 16, 2022May 18, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
35$254.36$8.9K14,334May 16, 2022May 18, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
19$251.57$4.8K14,423May 16, 2022May 18, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
20$252.49$5.0K14,403May 16, 2022May 18, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
34$253.87$8.6K14,369May 16, 2022May 18, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
41$274.75$11.3K14,396Apr 29, 2022May 3, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
30$275.62$8.3K14,366Apr 29, 2022May 3, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
22$276.72$6.1K14,344Apr 29, 2022May 3, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
17$273.37$4.6K14,437Apr 29, 2022May 3, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
10$278.04$2.8K14,334Apr 29, 2022May 3, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
1,554$227.86$354.1K14,454Feb 24, 2022Feb 28, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
712$232.51$165.5K16,008Feb 17, 2022Feb 22, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
474$237.74$112.7K16,720Feb 10, 2022Feb 14, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
2,100——10,353Feb 1, 2022Feb 3, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
3,634——13,987Feb 1, 2022Feb 3, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
3,207——17,194Feb 1, 2022Feb 3, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
47$216.88$10.2K8,253May 17, 2021May 19, 2021 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
65$215.95$14.0K8,300May 17, 2021May 19, 2021 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
1,351$207.57$280.4K12,043Mar 5, 2021Mar 8, 2021 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
844$210.64$177.8K9,969Mar 5, 2021Mar 8, 2021 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
1,119$208.39$233.2K10,924Mar 5, 2021Mar 8, 2021 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
1,460$211.67$309.0K8,509Mar 5, 2021Mar 8, 2021 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
256$212.28$54.3K8,253Mar 5, 2021Mar 8, 2021 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
SVP, General Counsel
111$209.37$23.2K10,813Mar 5, 2021Mar 8, 2021 ↗View →
Other insiders · VRTX
Loading peer insiders…
About this filer
CIK 0001847529
ROLE
SVP, General Counsel
PRIMARY
VRTX
COMPANIES
1
ACTIVE SINCE
Mar 2021
MARKETPEEL · /INSIDER/0001847529DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback